ArticleClinical and experimental reproductive medicine2026
Association of peripheral natural killer cell percentage with age, body mass index, serum anti- Müllerian hormone, various autoantibodies, and thrombophilia-related markers in women undergoing in vitro fertilization.
Article in Clinical and experimental reproductive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to assess associations between the peripheral natural killer (pNK) cell percentage and women's age, body mass index (BMI), serum anti-Müllerian hormone (AMH), autoantibodies, and thrombophilia-related markers among infertile women undergoing in vitro fertilization (IVF).
methodsWe enrolled 91 infertile Korean women (mean age 37.7 years [range, 26 to 48]) whose pNK cell percentage was measured either before IVF (22 women) or after ≥1 failed embryo transfer (ET) (69 women) between May 2017 and November 2022 at a single university hospital. Levels of antiphospholipid antibodies, thyroid-stimulating hormone (TSH), anti-thyroglobulin, anti-microsome, anti-nuclear antibodies, antithrombin III, protein C, and protein S were measured. Serum AMH was tested within 1 year of the pNK cell measurement.
resultsThe mean pNK cell percentage was 16.69%±7.60%, and 68 women (74.7%) had pNK ≥12%. Univariate analysis of five continuous variables (age, BMI, AMH, TSH, and number of failed ETs) showed that the pNK percentage was negatively associated with BMI (r=-0.213, p=0.043) and AMH (r=-0.213, p=0.049). Among 11 autoantibodies/markers, only β2-glycoprotein 1 immunoglobulin G (IgG) antibody was associated with a difference in pNK percentage (9.75%±4.72% in 4 positive vs. 17.63%±7.77% in 76 negative women, p=0.022). In a multivariate analysis of BMI, AMH, and β2-glycoprotein 1 IgG positivity, AMH (B=-0.249, p=0.028) was significantly negatively associated with the pNK percentage.
conclusionThe percentage of pNK cells is closely associated with serum AMH levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.